Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual...

cafead

Administrator
Staff member
  • cafead   Nov 02, 2023 at 11:53: AM
via Two oral presentations and five poster presentations at ASH Annual Meeting exhibit new and updated data in the clinical development program for ciltacabtagene autoleucel (cilta-cel)

article source